Publications

Towards integrated malaria molecular surveillance in Africa.

Dada, N; Simpson, VJ; Amenga-Etego, LN; ORIERO, E; Miotto, O; Torok, ME; Juma, EO; Williams, NA; Rajatileka, S; Ariani, CV; Raman, J; Ishengoma, DS;

2024

Trends in parasitology, (2024).40 11 10.1016/j.pt.2024.09.005.

Effect of RTS,S/AS01<sub>E</sub> vaccine booster dose on cellular immune responses in African infants and children.

Mitchell, RA; Macià, D; Jairoce, C; Mpina, M; Naidu, A; Chopo-Pizarro, A; Vázquez-Santiago, M; Campo, JJ; Aide, P; Aguilar, R; Daubenberger, C; Dobaño, C; Moncunill, G;

2024

NPJ vaccines, (2024).9 1 10.1038/s41541-024-00977-y.

The Effect of Malaria on Responses to Unrelated Vaccines in Animals and Humans: A Systematic Review and Meta-Analysis.

ZIRIMENYA, L; Natukunda, A; Nassuuna, J; Kabagenyi, J; NKURUNUNGI, G; ELLIOTT, AM; WEBB, EL;

2024

Parasite immunology, (2024).46 10 10.1111/pim.13067.

Evaluation of an electronic clinical decision support algorithm to improve primary care management of acute febrile illness in rural Cambodia: protocol for a cluster-randomised trial.

Chew, R; Wynberg, E; LIVERANI, M; Rekol, H; Nguon, C; Dysoley, L; Vanna, M; Callery, JJ; Mishra, A; Adhikari, B; Tripura, R; CHANDNA, A; Fegan, G; Waithira, N; Maude, RJ; Day, NP J; Peto, TJ; Lubell, Y;

2024

BMJ open, (2024).14 10 10.1136/bmjopen-2024-089616.

The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.

ZIRIMENYA, L; Natukunda, A; Nassuuna, J; NKURUNUNGI, G; Zziwa, C; Ninsiima, C; Kukundakwe, C; Nankabirwa, CM; Katushabe, C; Namusobya, LK; Oduru, G; Kabami, G; Kabali, J; Kayiwa, J; Kabagenyi, J; Van Dam, GJ; Corstjens, PL A M; COSE, S; WAJJA, A; Staedke, SG; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;

2024

The Lancet Global health, (2024).12 11 10.1016/S2214-109X(24)00281-X.

Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.

Natukunda, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Zziwa, C; Ninsiima, C; Tumusiime, J; Nyanzi, R; Namutebi, M; Kiwudhu, F; Van Dam, GJ; Corstjens, PL A M; Kizindo, R; Nkangi, R; Kabagenyi, J; Nassanga, B; COSE, S; WAJJA, A; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;

2024

The Lancet Global Health, (2024).12 11 10.1016/S2214-109X(24)00340-1.

A systematic review of sample size estimation accuracy on power in malaria cluster randomised trials measuring epidemiological outcomes.

BIGGS, J; Challenger, JD; Hellewell, J; Churcher, TS; COOK, J;

2024

BMC medical research methodology, (2024).24 1 10.1186/s12874-024-02361-9.

Who pays to treat malaria and how much? Analysis of the cost of illness, equity and economic burden of malaria in Uganda.

SNYMAN, K; PITT, C; Aturia, A; Aber, J; Gonahasa, S; Namuganga, JF; Nankabirwa, J; Arinaitwe, E; Maiteki-Sebuguzi, C; Katamba, H; Opigo, J; Matovu, F; Dorsey, G; Kamya, MR; Ochieng, W; Staedke, SG;

2024

Health Policy and Planning, (2024).40 1 10.1093/heapol/czae093.

Why does malaria transmission continue at high levels despite universal vector control? Quantifying persistent malaria transmission by Anopheles funestus in Western Province, Zambia.

Ashton, RA; Chanda, B; Chishya, C; Muyabe, R; Kaniki, T; Mambo, P; Mwenya, M; Mwaanga, G; Arnzen, A; Orange, E; Saili, K; Banda Yikona, H; Chulu, J; Chitoshi, C; Kyomuhangi, I; Miller, J; Silumbe, K; Hamainza, B; Littrell, M; Yukich, J; KLEINSCHMIDT, I; Chanda, J; Wagman, J; Eisele, TP;

2024

Parasites & vectors, (2024).17 1 10.1186/s13071-024-06457-5.

Brazil towards malaria elimination: A time-series analysis of imported cases from 2007 to 2022.

GARCIA, KK S; Laporta, GZ; SOREMEKUN, S; BOTTOMLEY, C; Abrahão, AA; Moresco, GG; DRAKELEY, C; Costa, AD P; Siqueira, AM;

2024

PLOS global public health, (2024).4 10 10.1371/journal.pgph.0003822.